Suppr超能文献

通过球形结晶技术制备多晶型混合物的团聚晶体以及吲哚美辛-依匹立唑的一种新络合物。

Preparations of agglomerated crystals of polymorphic mixtures and a new complex of indomethacin-epirizole by the spherical crystallization technique.

作者信息

Kawashima Y, Lin S Y, Ogawa M, Handa T, Takenaka H

出版信息

J Pharm Sci. 1985 Nov;74(11):1152-6. doi: 10.1002/jps.2600741104.

Abstract

Agglomerated crystals of indomethacin and epirizole were prepared by the spherical crystallization technique. The solvent used was ethanol-water-chloroform, ethyl acetate-water, or ethyl acetate-aqueous sodium chloride. From the ethanol-chloroform-water system, we obtained agglomerated crystals of a polymorphic mixture of the beta form of indomethacin (original form, gamma) and amorphous epirizole. When the mole percent of epirizole loaded into the system was less than 63 and 38% for the ethyl acetate-water and ethyl acetate-aqueous sodium chloride systems, respectively, the agglomerated crystals consisted of a polymorphic mixture of the alpha form of indomethacin and amorphous epirizole. When the respective mole percent of epirizole loaded was more than 65 and 43% in the aforementioned systems, a new complex of indomethacin-epirizole (molecular ratio equal to 2:1) was obtained. Recovery of complex from the drugs loaded in the ethyl acetate-aqueous sodium chloride system was higher than that in the ethyl acetate-water system, as a result of a salting-out effect. The solubility of indomethacin in the agglomerated complex in a solution of 30% aqueous ethanol and in disintegration test solution no. 2 (composition, 0.05 M KH2PO4 plus 0.0236 M, NaOH, pH 6.8), specified in the Japanese Pharmacopeia X (JPX), was higher than in the physical mixture (molecular ratio of indomethacin to epirizole equal to 2:1). In the ethanol solution, indomethacin was transformed into the gamma form during dissolution, and a decrease in solubility occurred. The process of dissolution of the tablet of the agglomerated complex was described by zero-order kinetics.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过球形结晶技术制备了吲哚美辛和依匹唑的团聚晶体。使用的溶剂为乙醇 - 水 - 氯仿、乙酸乙酯 - 水或乙酸乙酯 - 氯化钠水溶液。从乙醇 - 氯仿 - 水体系中,我们获得了吲哚美辛β晶型(原始晶型为γ)和无定形依匹唑的多晶型混合物的团聚晶体。当乙酸乙酯 - 水体系和乙酸乙酯 - 氯化钠水溶液体系中依匹唑的负载摩尔百分比分别小于63%和38%时,团聚晶体由吲哚美辛α晶型和无定形依匹唑的多晶型混合物组成。当上述体系中依匹唑的各自负载摩尔百分比大于65%和43%时,得到了一种新的吲哚美辛 - 依匹唑复合物(分子比等于2:1)。由于盐析效应,从乙酸乙酯 - 氯化钠水溶液体系中负载药物得到的复合物回收率高于乙酸乙酯 - 水体系。吲哚美辛在团聚复合物中在日本药典X(JPX)规定的30%乙醇水溶液和崩解试验溶液2(组成:0.05M KH2PO4加0.0236M NaOH,pH 6.8)中的溶解度高于物理混合物(吲哚美辛与依匹唑分子比等于2:1)。在乙醇溶液中,吲哚美辛在溶解过程中转变为γ晶型,溶解度降低。团聚复合物片剂的溶解过程符合零级动力学。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验